"Tom Bickle" wrote in message
...


It is generally more expensive to develop genetically
modified varieties and bring them to market than
conventional varieties, because of the additional research
and development work, and additional regulatory
requirements."

Do you, or do you not think Novartis lied to the committee, when they
said they have additional research and development work with GM
varieties?

What has Novartis got to do with it?

I generally just lurk here, but cannot resist. Torsten knows, because I
sent him email, that Novartis can have nothing to do with this. The
reason is that Novartis is not, and never has been, in the agro
business. When Novartis was formed by the fusion of Sandoz and
Ciba-Geigy they spun off their agro divisions as a new firm, Syngenta.

Your conclusion is not correct. Novartis was indeed formed by the merger of
Ciba Geigy and Sandoz. This took place in 1996. Syngenta was spun off from
Novartis in 1999.